The North America Omega 3 Market would witness market growth of 6.9% CAGR during the forecast period (2021-2027).
Omega-3 fatty acids are nutrients obtained from food (or supplements) that aid in the development and maintenance of a healthy body. It is important for the structure of every cell wall. Along with that, it also serves as an energy source and aid in the proper functioning of the heart, lungs, blood vessels, and immune system.
Many studies are being conducted to investigate the effect of omega-3 in baby food/infant nutrition due to the increasing popularity of omega-3 in other applications. It has been discovered that infants who consume DHA-enriched formula have better cognitive outcomes later in life. The majority of brain development in babies happens during pregnancy and the first two years of life. Infants require DHA and ARA throughout this time. These nutrients are crucial for brain development, which is why omega-3 infant nutrition supplements are becoming increasingly popular.
The United States Food and Drug Administration (FDA) has issued regulations that allow qualified health claims proving that these products can be used to reduce the risk of cardiovascular diseases, which is projected to raise its demand in this region. In addition, there is a rising investments by major corporations in the development of innovative technologies to increase the delivery and absorption of omega-3 acids in the body.
The US market dominated the North America Omega 3 Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $851.3 million by 2027. The Canada market is expected to witness a CAGR of 9.3% during (2021 - 2027). Additionally, The Mexico market would showcase a CAGR of 8.3% during (2021 - 2027).
Based on Type, the market is segmented into Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA), and Alpha-linolenic acid (ALA). Based on Application, the market is segmented into Supplements & Functional Foods, Pharmaceuticals, Infant Formula, Animal Feed & Pet Food and Others. Based on Source, the market is segmented into Marine Source and Plant Source. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Omega 3 Market is Estimated to reach $3 Billion by 2027, at a CAGR of 7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Aker BioMarine AS, GC Rieber VivoMega AS (GC Rieber group), Epax Norway AS (Pelagia Holding AS), FMC Corporation, BASF SE, Koninklijke DSM N.V., Lonza Group AG, Orkla ASA (Orkla Health), Croda International PLC, and Omega Protein Corporation (Cooke, Inc.).
Scope of the Study
Market Segments Covered in the Report:
By Type
- Docosahexaenoic acid (DHA)
- Eicosapentaenoic acid (EPA), and
- Alpha-linolenic acid (ALA)
By Application
- Supplements & Functional Foods
- Pharmaceuticals
- Infant Formula
- Animal Feed & Pet Food and
- Others
By Source
- Marine Source and
- Plant Source
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Aker BioMarine AS
- GC Rieber VivoMega AS (GC Rieber group)
- Epax Norway AS (Pelagia Holding AS)
- FMC Corporation
- BASF SE
- Koninklijke DSM N.V.
- Lonza Group AG
- Orkla ASA (Orkla Health)
- Croda International PLC
- Omega Protein Corporation (Cooke, Inc.)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Omega 3 Market, by Type
1.4.2 North America Omega 3 Market, by Application
1.4.3 North America Omega 3 Market, by Source
1.4.4 North America Omega 3 Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Product Launches and Product Expansions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Nov – 2021, Feb) Leading Players
Chapter 4. North America Omega 3 Market by Type
4.1 North America Docosahexaenoic acid (DHA) Market by Country
4.2 North America Eicosapentaenoic acid (EPA) Market by Country
4.3 North America Alpha-linolenic acid (ALA) Market by Country
Chapter 5. North America Omega 3 Market by Application
5.1 North America Supplements & Functional Foods Market by Country
5.2 North America Pharmaceuticals Market by Country
5.3 North America Infant Formula Market by Country
5.4 North America Animal Feed & Pet Food Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Omega 3 Market by Source
6.1 North America Marine Source Market by Country
6.2 North America Plant Source Market by Country
Chapter 7. North America Omega 3 Market by Country
7.1 US Omega 3 Market
7.1.1 US Omega 3 Market by Type
7.1.2 US Omega 3 Market by Application
7.1.3 US Omega 3 Market by Source
7.2 Canada Omega 3 Market
7.2.1 Canada Omega 3 Market by Type
7.2.2 Canada Omega 3 Market by Application
7.2.3 Canada Omega 3 Market by Source
7.3 Mexico Omega 3 Market
7.3.1 Mexico Omega 3 Market by Type
7.3.2 Mexico Omega 3 Market by Application
7.3.3 Mexico Omega 3 Market by Source
7.4 Rest of North America Omega 3 Market
7.4.1 Rest of North America Omega 3 Market by Type
7.4.2 Rest of North America Omega 3 Market by Application
7.4.3 Rest of North America Omega 3 Market by Source
Chapter 8. Company Profiles
8.1 Aker BioMarine AS
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 GC Rieber VivoMega AS (GC Rieber group)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Partnerships, Collaborations, and Agreements:
8.2.3.2 Product Launches and Product Expansions:
8.2.3.3 Geographical Expansions:
8.3 Epax Norway AS (Pelagia Holding AS)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.4 FMC Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.5 BASF SE
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Koninklijke DSM N.V.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.1 Recent strategies and developments:
8.6.1.1 Acquisition and Mergers:
8.7 Lonza Group AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Orkla ASA (Orkla Health)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Croda International PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Acquisition and Mergers:
8.10. Omega Protein Corporation (Cooke, Inc.)
8.10.1 Company Overview
TABLE 1 North America Omega 3 Market, 2017 - 2020, USD Million
TABLE 2 North America Omega 3 Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Omega 3 Market
TABLE 4 1.2.2 Acquisition and Mergers– Omega 3 Market
TABLE 5 Product Launches And Product Expansions – Omega 3 Market
TABLE 6 geographical Expansions – Omega 3 Market
TABLE 7 North America Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 8 North America Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 9 North America Docosahexaenoic acid (DHA) Market by Country, 2017 - 2020, USD Million
TABLE 10 North America Docosahexaenoic acid (DHA) Market by Country, 2021 - 2027, USD Million
TABLE 11 North America Eicosapentaenoic acid (EPA) Market by Country, 2017 - 2020, USD Million
TABLE 12 North America Eicosapentaenoic acid (EPA) Market by Country, 2021 - 2027, USD Million
TABLE 13 North America Alpha-linolenic acid (ALA) Market by Country, 2017 - 2020, USD Million
TABLE 14 North America Alpha-linolenic acid (ALA) Market by Country, 2021 - 2027, USD Million
TABLE 15 North America Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 16 North America Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 17 North America Supplements & Functional Foods Market by Country, 2017 - 2020, USD Million
TABLE 18 North America Supplements & Functional Foods Market by Country, 2021 - 2027, USD Million
TABLE 19 North America Pharmaceuticals Market by Country, 2017 - 2020, USD Million
TABLE 20 North America Pharmaceuticals Market by Country, 2021 - 2027, USD Million
TABLE 21 North America Infant Formula Market by Country, 2017 - 2020, USD Million
TABLE 22 North America Infant Formula Market by Country, 2021 - 2027, USD Million
TABLE 23 North America Animal Feed & Pet Food Market by Country, 2017 - 2020, USD Million
TABLE 24 North America Animal Feed & Pet Food Market by Country, 2021 - 2027, USD Million
TABLE 25 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 26 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 27 North America Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 28 North America Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 29 North America Marine Source Market by Country, 2017 - 2020, USD Million
TABLE 30 North America Marine Source Market by Country, 2021 - 2027, USD Million
TABLE 31 North America Plant Source Market by Country, 2017 - 2020, USD Million
TABLE 32 North America Plant Source Market by Country, 2021 - 2027, USD Million
TABLE 33 North America Omega 3 Market by Country, 2017 - 2020, USD Million
TABLE 34 North America Omega 3 Market by Country, 2021 - 2027, USD Million
TABLE 35 US Omega 3 Market, 2017 - 2020, USD Million
TABLE 36 US Omega 3 Market, 2021 - 2027, USD Million
TABLE 37 US Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 38 US Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 39 US Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 40 US Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 41 US Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 42 US Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 43 Canada Omega 3 Market, 2017 - 2020, USD Million
TABLE 44 Canada Omega 3 Market, 2021 - 2027, USD Million
TABLE 45 Canada Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 46 Canada Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 47 Canada Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 48 Canada Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 49 Canada Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 50 Canada Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 51 Mexico Omega 3 Market, 2017 - 2020, USD Million
TABLE 52 Mexico Omega 3 Market, 2021 - 2027, USD Million
TABLE 53 Mexico Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 54 Mexico Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 55 Mexico Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 56 Mexico Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 57 Mexico Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 58 Mexico Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 59 Rest of North America Omega 3 Market, 2017 - 2020, USD Million
TABLE 60 Rest of North America Omega 3 Market, 2021 - 2027, USD Million
TABLE 61 Rest of North America Omega 3 Market by Type, 2017 - 2020, USD Million
TABLE 62 Rest of North America Omega 3 Market by Type, 2021 - 2027, USD Million
TABLE 63 Rest of North America Omega 3 Market by Application, 2017 - 2020, USD Million
TABLE 64 Rest of North America Omega 3 Market by Application, 2021 - 2027, USD Million
TABLE 65 Rest of North America Omega 3 Market by Source, 2017 - 2020, USD Million
TABLE 66 Rest of North America Omega 3 Market by Source, 2021 - 2027, USD Million
TABLE 67 Key Information – Aker BioMarine AS
TABLE 68 Key Information – GC Rieber VivoMega AS
TABLE 69 Key Information – Epax Norway AS
TABLE 70 Key Information – FMC Corporation
TABLE 71 Key Information – BASF SE
TABLE 72 Key Information – Koninklijke DSM N.V.
TABLE 73 Key Information – Lonza Group AG
TABLE 74 Key Information – Orkla ASA
TABLE 75 Key Information – Croda International PLC
TABLE 76 key information – Omega Protein Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Nov – 2021, Feb) Leading Players
FIG 5 Recent strategies and developments: Aker BioMarine AS
FIG 6 Recent strategies and developments: GC Rieber VivoMega AS
FIG 7 Recent strategies and developments: Orkla ASA